Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0234
+0.0004 (1.74%)
At close: Oct 15, 2026
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $2.68 million as of October 15, 2026. It is the 47,137th most valuable company in the world and the 6,321st biggest in the United States. Its market cap has decreased by 56.85% in one year.
Market Cap
2.68M
Enterprise Value
3.76M
Revenue
n/a
Global Rank
Country Rank
#6,321 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 2.68M, a decrease of -89.48%. That is a compound annual growth rate of -24.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 2.68M | -67.08% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacific Software | 3.12M |
| Affymax | 3.10M |
| Vaccinex | 2.81M |
| Aditxt | 2.79M |
| GPL Holdings | 2.56M |
| Enzolytics | 2.42M |
| Mosaic ImmunoEngineering | 2.41M |
| AccuStem Sciences | 2.37M |